NEW ORLEANS — Treatment of severe tricuspid regurgitation with transcatheter repair was safe, reduced severity of tricuspid regurgitation and led to improvements in quality of life at 1 year, according to results of the TRILUMINATE Pivotal trial.
“[The] TRILUMINATE Pivotal [trial] is a pioneering study as the first randomized clinical trial in this unique population of patients with
Findings from the TRILUMINATE Pivotal trial found no significant difference in survival or hospitalization after one year of follow-up, according to research presented on the first day of the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC. The study did find that in patients with a poorly functioning tricuspid valve in the heart, a minimally invasive procedure using a clip to repair the valve was safe and improved both the valve’s functioning and patients’ quality of life at one year compared with the best available medical therapy.
Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR)
New Data Show Superiority of Abbott s TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.